SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) - ANVISA Registration 81086830047

Access comprehensive regulatory information for SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81086830047 and manufactured by VEDALAB. The registration is held by FASTTEST DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until Mar 30, 2032.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, GENRUI BIOTECH INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81086830047
2 Related Devices
Registration Details
ANVISA Registration Number: 81086830047
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

81086830047

25351052652202294

20037992000139

Company Information

VEDALAB
France
PT: FRANÇA

Dates and Status

Mar 30, 2022

30/03/2032

09/18/2025 19:00:01

Registration Details

81086830047

25351052652202294

20037992000139

Dates and Status

Mar 30, 2022

30/03/2032

09/18/2025 19:00:01